Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (57)
  • 2024 (27)
  • 2023 (19)
  • 2022 (23)
  • 2021 (46)
  • 2020 (45)
  • 2019 (42)
  • 2018 (45)
  • 2017 (36)
  • 2016 (22)
  • 2015 (15)
  • 2014 (22)
  • 2013 (39)
  • 2012 (8)
  • 2011 (32)

Subject

  • Drug Trafficking (49)
  • Take Back Day (41)
  • Prescription Drugs (31)
  • Outreach/Drug Prevention (23)
  • Fake Pills (21)
  • Fentanyl Awareness (21)
  • Synthetic drugs (21)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Pharmaceuticals/Pharmacists/Physicians (14)
  • Congressional Affairs (13)
  • Arrests/Convictions - Major (12)
  • Guns/Weapons (11)
  • Major Law Enforcement Operation (11)
  • Press Conferences (11)
  • Diversion Division (10)
  • Red Ribbon (10)
  • Money Laundering (9)
  • OCDETF/Task Force (8)
  • One Pill Can Kill (8)
  • Overdose (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Seizures (Drugs/Property) (7)
  • Narcoterrorism (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Critical Incident (3)
  • Gangs (3)
  • Task Forces/Task Force Officers (3)
  • Dark Web- Internet Trafficking (2)
  • Fentanyl Free America (2)
  • Guilty Plea (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Campaigns (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (50)
  • Cocaine (25)
  • Methamphetamine (23)
  • Heroin (12)
  • Marijuana (Cannabis) (8)
  • Synthetic Opioids (6)
  • Opioids (5)
  • Oxycodone (5)
  • Marijuana Concentrates (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)
  • Steroids (1)

Field Division

  • New England (2349)
  • New York (1519)
  • Houston (892)
  • San Francisco (842)
  • Miami (825)
  • St. Louis (808)
  • Seattle (801)
  • Atlanta (763)
  • Chicago (621)
  • Washington, DC (613)
  • New Jersey (493)
  • New Orleans (470)
  • Detroit (360)
  • El Paso (345)
  • Dallas (315)
  • Los Angeles (299)
  • Phoenix (271)
  • San Diego (244)
  • Rocky Mountain (165)
  • Philadelphia (140)
  • Omaha (134)
  • Caribbean (79)
  • Caribbean (1)
  • Headquarters (408)
  • Louisville (76)
Clear All Results
PRESS RELEASE

DEA Investigations Lead To Treasury 311 Patriot Act Designation Against Hizballah-Backed Financial Institutions

April 23, 2013
WASHINGTON - The U.S. Department of the Treasury today named two Lebanese exchange houses, Kassem Rmeiti & Co. For (Rmeiti Exchange) and Halawi Exchange Co. (Halawi Exchange), as foreign financial institutions of primary money laundering concern under Section 311 of the USA PATRIOT (Section 311) - the first time the...
April 23, 2013
PRESS RELEASE

Antonio Indjai, Chief Of The Guinea-Bissau Armed Forces, Charged With Conspiring To Sell Surface-to-Air Missiles To A Foreign Terrorist Organization And Narco-Terrorism Conspiracy

April 18, 2013
WASHINGTON - - DEA Administrator Michele M. Leonhart and Preet Bharara, the United States Attorney for the Southern District of New York, announced today the unsealing of charges against Antonio Indjai, the head of the Guinea-Bissau Armed Forces, for conspiring to provide aid to the Fuerzas Armadas Revolucionarios de (the...
April 18, 2013
PRESS RELEASE

DEA Continues To Act Against Synthetic Drugs

April 12, 2013
WASHINGTON - Today the United States Drug Enforcement (DEA) published a Final Rule to permanently control 3,4-methylenedioxy-N-(methylone) and a Notice of Intent to temporarily schedule three synthetic cannabinoids. The first of two notices published in the Federal Register this morning is a Final Rule permanently placing methylone, a synthetic stimulant...
April 12, 2013
PRESS RELEASE

DEA Leads Major Narco-Terror Operation

April 04, 2013
WASHINGTON, D.C. - DEA Administrator Michele M. Leonhart and U.S. Attorney Preet Bharara of the Southern District of New York announced that five defendants - Jose Americo Bubo Na Tchuto, the former head of the Guinea-Bissau navy; Manuel Mamadi Mane; Saliu Sisse; Papis Djeme; and Tchamy Yala - arrived in...
April 04, 2013
PRESS RELEASE

CVS To Pay $11 Million To Settle Civil Penalty Claims Involving Violations Of Controlled Substances Act

April 03, 2013
WASHINGTON - CVS Pharmacy, Inc., and Oklahoma CVS Pharmacy, L.L.C., (collectively “CVS”), have agreed to pay $11,000,000 to the United States to settle civil penalty claims for record-keeping violations under the Controlled Substances Act and related regulations, announced Administrator Michele M. Leonhart of the Drug Enforcement (DEA) and Sanford C...
April 03, 2013
PRESS RELEASE

High Ranking Gulf Cartel Member Convicted In Washington For Drug Trafficking

February 26, 2013
WASHINGTON - Aurelio Cano Flores, a Mexican national and high ranking member of the Gulf Cartel, was found guilty today by a federal jury of conspiring to import multi-ton quantities of cocaine and marijuana into the United States, announced Assistant Attorney General Lanny A. Breuer of the Justice Department’s Criminal...
February 26, 2013
PRESS RELEASE

High-Ranking Member Of Mexican “Los Zetas” Cartel Pleads Guilty To Drug Conspiracy Charges

February 01, 2013
WASHINGTON - Jesus Enrique Rejon Aguilar, aka “Mamito” and “Caballero,” a high ranking member of the “Los Zetas” drug cartel, pleaded guilty today to conspiracy to import multi-ton quantities of cocaine and marijuana into the United States, announced Administrator Michele M. Leonhart of the Drug Enforcement (DEA) and Assistant Attorney...
February 01, 2013
PRESS RELEASE

Richard Ammar Chichakli Arrested On Money Laundering, Wire Fraud, And Conspiracy Charges

January 10, 2013
WASHINGTON - U.S. Drug Enforcement (DEA) Administrator Michele Leonhart and Manhattan U.S. Attorney Preet Bharara, announced that Richard Ammar Chichakli, an associate of convicted international arms dealer, Viktor Bout, was arrested yesterday in Australia for, among other things, allegedly conspiring with Bout and others to violate the International Emergency Economic...
January 10, 2013
PRESS RELEASE

DEA Publishes Proposed Regulations For Disposing Of Controlled Substance Prescription Drugs

December 26, 2012
WASHINGTON, D.C. - The Drug Enforcement (DEA) published its Notice of Proposed Rulemaking for the Disposal of Controlled Substances in the Federal Register Dec. 21. The proposed regulations seek to implement the Secure and Responsible Drug Disposal Act of 2010. According to the 2011 Substance Abuse and Mental Health Services...
December 26, 2012
PRESS RELEASE

DEA News: HSBC Holdings Plc. And HSBC Bank USA N.A. Admit To Anti-Money Laundering And Sanctions Violations, Forfeit $1.256 Billion In Deferred Prosecution Agreement

December 11, 2012
DEC 11 - (WASHINGTON, D.C.) - - DEA and other federal officials announced today that HSBC Holdings (HSBC Group) - a United Kingdom corporation headquartered in London - and HSBC Bank USA N.A. (HSBC Bank USA) (together, HSBC) - a federally chartered banking corporation headquartered in McLean, Va. - have...
December 11, 2012
Showing 431 - 440 of 478 results

Pagination

  • First page «
  • Previous page ‹
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Current page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster